EMH.V - Emerald Health Therapeutics, Inc.

TSXV - TSXV Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 555.54M
Enterprise Value 379.62M
Trailing P/E N/A
Forward P/E 1-1.64
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)3.26
Price/Book (mrq)0.27
Enterprise Value/Revenue 34.68
Enterprise Value/EBITDA 6-1.63

Trading Information

Stock Price History

Beta (5Y Monthly) 1.96
52-Week Change 3-87.73%
S&P500 52-Week Change 326.46%
52 Week High 34.6600
52 Week Low 30.2650
50-Day Moving Average 30.3253
200-Day Moving Average 31.1867

Share Statistics

Avg Vol (3 month) 3712.32k
Avg Vol (10 day) 3759.87k
Shares Outstanding 5160.99M
Float 128.12M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Dec. 30, 2019) 4468.42k
Short Ratio (Dec. 30, 2019) 40.59
Short % of Float (Dec. 30, 2019) 4N/A
Short % of Shares Outstanding (Dec. 30, 2019) 40.29%
Shares Short (prior month Nov. 28, 2019) 41.57M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Sep. 08, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2018
Most Recent Quarter (mrq)Sep. 29, 2019


Profit Margin -204.93%
Operating Margin (ttm)-314.38%

Management Effectiveness

Return on Assets (ttm)-14.39%
Return on Equity (ttm)-19.36%

Income Statement

Revenue (ttm)17.02M
Revenue Per Share (ttm)0.11
Quarterly Revenue Growth (yoy)2,795.90%
Gross Profit (ttm)-270.21k
EBITDA -48.79M
Net Income Avi to Common (ttm)-34.87M
Diluted EPS (ttm)-0.2240
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.39M
Total Cash Per Share (mrq)0.04
Total Debt (mrq)28.04M
Total Debt/Equity (mrq)14.43
Current Ratio (mrq)1.14
Book Value Per Share (mrq)1.26

Cash Flow Statement

Operating Cash Flow (ttm)-37.09M
Levered Free Cash Flow (ttm)-56.37M